UFF
RMD icon

USA Financial Formulas’s ResMed RMD Stock Holding History

USA Financial Formulas’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-5
Closed -$1.12K – 511
2026
Q1 		$1.12K Hold
5
– – ﹤0.01% 330
2025
Q4 		$1.2K Sell
5
-2,017
-100% -$516K ﹤0.01% 294
2025
Q3 		$553K Buy
+2,022
New +$552K 0.1% 87
2021
Q1 		– Sell
-5
Closed -$1K – 413
2020
Q4 		$1K Hold
5
– – ﹤0.01% 298
2020
Q3 		$1K Hold
5
– – ﹤0.01% 290
2020
Q2 		$1K Hold
5
– – ﹤0.01% 200
2020
Q1 		$1K Sell
5
-17,859
-100% -$2.84M ﹤0.01% 188
2019
Q4 		$2.77M Buy
+17,864
New +$2.57M 1.15% 31

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

USA Financial Formulas's RMD Position: Q2 2026 in Review

USA Financial Formulas sold out of ResMed (RMD) in Q2 2026, closing a stake of 5 shares — an estimated $1.12K sold.

USA Financial Formulas first reported a position in RMD in Q4 2019 and held it in 8 quarters. The position peaked at $2.77M in Q4 2019. 887 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • USA Financial Formulas reported no remaining ResMed position as of Q2 2026 after selling out during the quarter.
  • USA Financial Formulas sold 5 ResMed shares in Q2 2026, an estimated $1.12K.
  • USA Financial Formulas first reported a position in ResMed in Q4 2019 and held it in 8 quarters.
  • USA Financial Formulas's ResMed position peaked at $2.77M in Q4 2019.
  • 887 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on USA Financial Formulas's 13F filing for Q2 2026, filed 4 Aug 2026.